Information de reference pour ce titreAccession Number: | 00003135-200210000-00015.
|
Author: | Oyibo, S. O.; Prasad, Y. D. M.; Jackson, N. J.; Jude, E. B.; Boulton, A. J. M.
|
Institution: | Department of Diabetes, Manchester Royal Infirmary, Manchester, UK
|
Title: | |
Source: | Diabetic Medicine. 19(10):870-873, October 2002.
|
Abstract: | Aims: Peripheral neuropathy affects 30% of Type 1 diabetic patients. Unfortunately, 10-20% of affected patients have disabling symptoms. The aim of this study was to examine the relationship between blood glucose excursions and pain in patients with symptomatic diabetic neuropathy.
Methods: Twenty Type 1 diabetic patients with peripheral neuropathy (10 painful and 10 painless) wore a continuous glucose monitoring system for 3 days. Symptomatic patients kept a daily pain score diary. The mean amplitude of glycaemic excursions (MAGE) and the M-values (measure of glucose deviations from an arbitrarily selected point) were calculated.
Results: Groups were matched for (mean +/- SD) age: 52.0 +/- 11.1 years; duration of diabetes: 24.8 +/- 10.7 years; HbA1c: 9.7 +/- 2.3%; duration of neuropathy: 5.6 +/- 2.6 years; and CGMS performance. The painful group had a greater mean glucose (12.1 +/- 2.9 mmol/l vs. 9.3 +/- 1.9 mmol/l, P = 0.02), a greater M-value (68.4 vs. 31.1, P = 0.02) and more glycaemic excursions (13 vs. 10, P < 0.01), compared with the painless group. However, there was no difference in the MAGE between both groups, and no correlation between the number of glycaemic excursions and the number of painful episodes in the painful group.
Conclusions: Patients with painful neuropathy have greater glucose flux and possibly poorer diabetes control, compared with patients with painless neuropathy.
(C) 2002 Blackwell Science Ltd.
|
Author Keywords: | painful neuropathy; glucose excursions.
|
References: | 1 Young MJ, Boulton AJM, Williams DRR, Mcleod AF, Sonksen PH. A multi-center study of the prevalence of diabetic neuropathy in patients attending UK diabetic clinics. Diabetologia 1993; 36: 150-154.
2 Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood glucose control on the late complications of Type 1 diabetes. Lancet 1993; 341: 1306-1309.
3 Cotter MA, Cameron NE. The aetiopathogenesis of diabetic neuropathy: metabolic theories. In Boulton AJM ed. Diabetic Neuropathy. Carnforth, UK: Marius Press, 1997: 97-119.
4 Cotter MA, Cameron NE. The aetiopathogenesis of diabetic neuropathy: vascular theories. In Boulton AJM ed. Diabetic Neuropathy. Carnforth, UK: Marius Press, 1997: 121-146.
5 Boulton AJM. Current and emerging treatments of diabetic neuropathies. Diabetes Rev 1999; 7: 379-386.
6 Boulton AJM. What causes neuropathic pain? J Diab Comp 1992; 6: 58-63.
7 Britland ST, Young RJ, Sharma AK, Clarke BF. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain 1992; 48: 361-370.
8 Veves A, Young MJ, Manes C, Boulton AJM. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994; 17: 1200-1202.
9 Tsigos C, Reed P, Weinkove C, White A, Young RJ. Plasma norepinephrine in sensory diabetic polyneuropathy. Diabetes Care 1993; 16: 722-727.
10 Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996; 39: 329-335.
11 Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic neuropathy: effects of glucose on pain perception in humans. Am J Med 1984; 77: 79-82.
12 Akunne HC, Soliman KF. The role of opioid receptors in diabetes and hyperglycaemia-induced changes in pain threshold in the rat. Psychopharmacology 1987; 93: 167-172.
13 Chan AW, MacFarlane IA, Bowsher D. Short term fluctuations in blood glucose concentrations do not alter pain perception in diabetic patients with and without painful peripheral neuropathy. Diabetes Res 1990; 14: 15-19.
14 Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000; 2: 49-56.
15 Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycaemic control after its use in paediatric type 1 diabetic subjects. Diabetes Care 2001; 24: 2030-2034.
16 Bloom S, Till S, Sonksen P, Smith S. Use of biothesiometer to measure individual vibration perception thresholds and their variation in 519 non-diabetic subjects. Br Med J 1984; 288: 1793-1795.
17 Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycaemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
18 Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982; 5: 386-390.
|
Language: | English.
|
Document Type: | Short reports.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0742-3071
|
NLM Journal Code: | dme, 8500858
|
Annotation(s) | |
|
|